Stroke occurring in patients with cognitive impairment or dementia

ABSTRACT

One in six patients admitted for stroke was previously demented. These patients have less access to appropriate stroke care, although little is known about their optimal management.

Objective To determine how pre-stroke cognitive impairment can be detected, its mechanism, and influence on outcome and management.

Methods Literature search.

Results (i) A systematic approach with the Informant Questionnaire of Cognitive Decline in the Elderly is recommended; (ii) Pre-stroke cognitive impairment may be due to brain lesions of vascular, degenerative, or mixed origin; (iii) Patients with pre-stroke dementia, have worse outcomes, more seizures, delirium, and depression, and higher mortality rates; they often need to be institutionalised after their stroke; (iv) Although the safety profile of treatment is not as good as that of cognitively normal patients, the risk:benefit ratio is in favour of treating these patients like others.

Conclusion Patients with cognitive impairment who develop a stroke have worse outcomes, but should be treated like others.

RESUMO

Um em cada seis pacientes internados em decorrência de acidente vascular cerebral (AVC) apresenta diagnóstico prévio de demência. Estes indivíduos têm menor acesso à assistência recomendada para pacientes com AVC, mas pouco ainda se sabe em relação aos cuidados médicos ideais que devem receber.

Objetivo Determinar como o comprometimento cognitivo prévio ao AVC pode ser detectado, qual o mecanismo etiológico subjacente, e as consequências para o prognóstico e para o acompanhamento clínico.

Método Pesquisa bibliográfica.

Resultados (i) O rastreamento sistemático com o Informant Questionnaire of Cognitive Decline in the Elderly é recomendado; (ii) O comprometimento cognitivo preexistente pode ser devido a lesões cerebrais de origem vascular, degenerativa ou mista; (iii) Pacientes com demência prévia ao AVC têm pior prognóstico, maior frequência de crises epilépticas, de delirium e depressão, além de taxas de mortalidade mais altas; eles frequentemente são institucionalizados após o AVC; (iv) Embora a tolerabilidade às medicações não seja tão boa quanto a de pacientes com AVC sem comprometimento cognitivo, a relação risco/benefício é a favor de tratamento similar àquele oferecido aos demais pacientes.

Conclusão Pacientes com comprometimento cognitivo que apresentam AVC têm pior prognóstico, porém eles devem ser tratados de modo semelhante aos demais casos.

stroke - cerebral infarction - cerebral hemorrhage - dementia - mild cognitive impairment

acidente vascular cerebral - infarto cerebral - hemorragia cerebral - demência - comprometimento cognitivo leve

Support:

University Lille 2, CHU Lille, INSERM.

Publikationsverlauf

Eingereicht: 18. September 2016

Angenommen: 10. Oktober 2016

Artikel online veröffentlicht:
05. September 2023

• References

• 1 Mas JL, Zuber M. Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. French Study Group on Patent Foramen Ovale and Atrial Septal Aneurysm. Am Heart J. 1995;130(5):1083-8. http://doi.org/10.1016/0002-8703(95)90212-0
• 2 Rohweder G, Ellekjær H, Salvesen Ø, Naalsund E, Indredavik B. Functional outcome after common poststroke complications occurring in the first 90 days. Stroke. 2015;46(1):65-70. http://doi.org/10.1161/STROKEAHA.114.006667
• 3 Hartmann A, Rundek T, Mast H, Paik MC, Boden-Albala B, Mohr JP et al. Mortality and causes of death after first ischemic stroke: the Northern Manhattan Stroke Study. Neurology. 2001;57(11):2000-5. http://doi.org/10.1212/WNL.57.11.2000
• 4 Steiner T, Rosand J, Diringer M. Intracerebral hemorrhage associated with oral anticoagulant therapy: current practices and unresolved questions. Stroke. 2006;37(1):256-62. http://doi.org/10.1161/01.STR.0000196989.09900.f8
• 5 Cordonnier C, Hénon H, Derambure P, Pasquier F, Leys D. Influence of pre-existing dementia on the risk of post-stroke epileptic seizures. J Neurol Neurosurg Psychiatry. 2005;76(12):1649-53. http://doi.org/10.1136/jnnp.2005.064535
• 6 Rossi C, De Herdt V, Dequatre-Ponchelle N, Hénon H, Leys D, Cordonnier C et al. Incidence and predictors of late seizures in intracerebral hemorrhages. Stroke. 2013;44(6):1723-5. http://doi.org/10.1161/STROKEAHA.111.000232
• 7 Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol. 2009;8(11):1006-18. http://doi.org/10.1016/S1474-4422(09)70236-4
• 8 Leys D, Hénon H, Mackowiak-Cordoliani MAA, Pasquier F. Poststroke dementia. Lancet Neurol. 2005;4(11):752-9. http://doi.org/10.1016/S1474-4422(05)70221-0
• 9 Hackett ML, Yapa C, Parag V, Anderson CS. Frequency of depression after stroke: a systematic review of observational studies. Stroke. 2005;36(6):1330-40. http://doi.org/10.1161/01.STR.0000165928.19135.35
• 10 Jönsson AC, Delavaran H, Iwarsson S, Ståhl A, Norrving B, Lindgren A. Functional status and patient-reported outcome 10 years after stroke: the Lund Stroke Register. Stroke. 2014;45(6):1784-90. http://doi.org/10.1161/STROKEAHA.114.005164
• 11 Pasquier F, Leys D. Why are stroke patients prone to develop dementia? J Neurol. 1997;244(3):135-42. http://doi.org/10.1007/s004150050064
• 12 Hénon H, Pasquier F, Durieu I, Godefroy O, Lucas C, Lebert F et al. Preexisting dementia in stroke patients. Baseline frequency, associated factors, and outcome. Stroke. 1997;28(12):2429-36. http://doi.org/10.1161/01.STR.28.12.2429
• 13 Barba R, Castro MD, Mar Morin M, Rodriguez-Romero R, Rodríguez-García E, Cantón R et al. Prestroke dementia. Cerebrovasc Dis. 2001;11(3):216-24. http://doi.org/10.1159/000047642
• 14 Klimkowicz A, Dziedzic T, Slowik A, Szczudlik A. Incidence of pre- and poststroke dementia: cracow stroke registry. Dement Geriatr Cogn Disord. 2002;14(3):137-40. http://doi.org/10.1159/000063599
• 15 Tatemichi TK, Desmond DW, Paik M, Figueroa M, Gropen TI, Stern Y et al. Clinical determinants of dementia related to stroke. Ann Neurol. 1993;33(6):568-75. http://doi.org/10.1002/ana.410330603
• 16 Jorm AF, Jacomb PA. The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychol Med. 1989;19(4):1015-22. http://doi.org/10.1017/S0033291700005742
• 17 Jorm AF. A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): development and cross-validation. Psychol Med. 1994;24(1):145-53. http://doi.org/10.1017/S003329170002691X
• 18 Jorm AF. The Informant Questionnaire on cognitive decline in the elderly (IQCODE): a review. Int Psychogeriatr. 2004;16(3):275-93. http://doi.org/10.1017/S1041610204000390
• 19 Murao K, Leys D, Jacquin A, Kitazono T, Bordet R, Béjot Y et al. Thrombolytic therapy for stroke in patients with preexisting cognitive impairment. Neurology. 2014;82(23):2048-54. http://doi.org/10.1212/WNL.20160187201601870493
• 20 Murao K, Bodenant M, Cordonnier C, Bombois S, Hénon H, Pasquier F et al. Does pre-existing cognitive impairment no-dementia influence the outcome of patients treated by intravenous thrombolysis for cerebral ischaemia? J Neurol Neurosurg Psychiatry. 2013;84(12):1412-4. http://doi.org/10.1136/jnnp-2013-305281
• 21 Cordonnier C, Leys D, Dumont F, Deramecourt V, Bordet R, Pasquier F et al. What are the causes of pre-existing dementia in patients with intracerebral haemorrhages? Brain. 2010;133(11):3281-9. http://doi.org/10.1093/brain/awq246
• 22 Mounier-Vehier F, Leys D, Rondepierre P, Godefroy O, Pruvo JPP. Silent infarcts in patients with ischemic stroke are related to age and size of the left atrium. Stroke. 1993;24(9):1347-51. http://doi.org/10.1161/01.STR.24.9.1347
• 23 Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2010;341:c3666. http://doi.org/10.1136/bmj.c3666
• 24 Debette S, Bombois S, Bruandet A, Delbeuck X, Lepoittevin S, Delmaire C et al. Subcortical hyperintensities are associated with cognitive decline in patients with mild cognitive impairment. Stroke. 2007;38(11):2924-30. http://doi.org/10.1161/STROKEAHA.107.488403
• 25 Bombois S, Debette S, Bruandet A, Delbeuck X, Delmaire C, Leys D et al. Vascular subcortical hyperintensities predict conversion to vascular and mixed dementia in MCI patients. Stroke. 2008;39(7):2046-51. http://doi.org/10.1161/STROKEAHA.107.505206
• 26 Cordonnier C, Al-Shahi Salman R, Wardlaw J. Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting. Brain. 2007;130(8):1988-2003. http://doi.org/10.1093/brain/awl387
• 27 Hénon H, Pasquier F, Durieu I, Pruvo JP, Leys D. Medial temporal lobe atrophy in stroke patients: relation to pre-existing dementia. J Neurol Neurosurg Psychiatry. 1998;65(5):641-7. http://doi.org/10.1136/jnnp.65.5.641
• 28 Chen Y, Wang J, Zhang J, Zhang T, Chen K, Fleisher A et al. Aberrant functional networks connectivity and structural atrophy in silent lacunar infarcts: relationship with cognitive impairments. J Alzheimers Dis. 2014;42(3):841-50. http://doi.org/10.3233/JAD-140948
• 29 Peters N, Holtmannspötter M, Opherk C, Gschwendtner A, Herzog J, Sämann P et al. Brain volume changes in CADASIL: a serial MRI study in pure subcortical ischemic vascular disease. Neurology. 2006;66(10):1517-22. http://doi.org/10.1212/01.wnl.0000216271.96364.50
• 30 Jouvent E, Viswanathan A, Mangin JF, O’Sullivan M, Guichard JP, Gschwendtner A et al. Brain atrophy is related to lacunar lesions and tissue microstructural changes in CADASIL. Stroke. 2007;38(6):1786-90. http://doi.org/10.1161/STROKEAHA.106.478263
• 31 Hénon H, Lebert F, Durieu I, Godefroy O, Lucas C, Pasquier F et al. Confusional state in stroke: relation to preexisting dementia, patient characteristics, and outcome. Stroke. 1999;30(4):773-9. http://doi.org/10.1161/01.STR.30.4.773
• 32 Hénon H, Durieu I, Lebert F, Pasquier F, Leys D et al. Influence of prestroke dementia on early and delayed mortality in stroke patients. J Neurol. 2003;250(1):10-6. http://doi.org/10.1007/s00415-003-0917-3
• 33 Verdelho A, Hénon H, Lebert F, Pasquier F, Leys D et al. Depressive symptoms after stroke and relationship with dementia: A three-year follow-up study. Neurology. 2004;62(6):905-11. http://doi.org/10.1212/01.WNL.0000115107.66957.8C
• 34 Pasquini M, Leys D, Rousseaux M, Pasquier F, Hénon H, Hénon H. Influence of cognitive impairment on the institutionalisation rate 3 years after a stroke. J Neurol Neurosurg Psychiatry. 2007;78(1):56-9. http://doi.org/10.1136/jnnp.2006.102533
• 35 European Stroke Organisation Executive Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis. 2008;25(5):457-507. http://doi.org/10.1159/000131083
• 36 Saposnik G, Cote R, Rochon PA, Mamdani M, Liu Y, Raptis S et al. Care and outcomes in patients with ischemic stroke with and without preexisting dementia. Neurology. 2011;77(18):1664-73. http://doi.org/10.1212/WNL.0b013e31823648f1
• 37 Meretoja A, Putaala J, Tatlisumak T, Atula S, Artto V, Curtze S et al. Off-label thrombolysis is not associated with poor outcome in patients with stroke. Stroke. 2010;41(7):1450-8. http://doi.org/10.1161/STROKEAHA.109.576140
• 38 Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet. 2012;379(9834):2352-63. http://doi.org/10.1016/S0140-6736(12)60768-5
• 39 Wardlaw JM, Murray V, Berge E, del Zoppo G, Sandercock P, Lindley RL et al. Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis. Lancet. 2012;379(834):2364-72. http://doi.org/10.1016/S0140-6736(12)60738-7
• 40 Leys D, Cordonnier C. rt-PA for ischaemic stroke: what will the next question be? Lancet. 2012;379(9834):2320-1. http://doi.org/10.1016/S0140-6736(12)60822-8
• 41 Viswanathan A, Greenberg SM. Cerebral amyloid angiopathy in the elderly. Ann Neurol. 2011;70(6):871-80. http://doi.org/10.1002/ana.22516
• 42 Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol. 2013;12(5):483-97. http://doi.org/10.1016/S1474-4422(13)70060-7
• 43 Whiteley WN, Slot KB, Fernandes P, Sandercock P, Wardlaw J. Risk factors for intracranial hemorrhage in acute ischemic stroke patients treated with recombinant tissue plasminogen activator: a systematic review and meta-analysis of 55 studies. Stroke. 2012;43(11):2904-9. http://doi.org/10.1161/STROKEAHA.112.665331
• 44 Fiehler J, Albers GW, Boulanger JM, Derex L, Gass A, Hjort N et al. Bleeding risk analysis in stroke imaging before thromboLysis (BRASIL): pooled analysis of T2*-weighted magnetic resonance imaging data from 570 patients. Stroke. 2007;38(10):2738-44. http://doi.org/10.1161/STROKEAHA.106.480848
• 45 Palumbo V, Boulanger JM, Hill MD, Inzitari D, Buchan AM. Leukoaraiosis and intracerebral hemorrhage after thrombolysis in acute stroke. Neurology. 2007;68(13):1020-4. http://doi.org/10.1212/01.wnl.0000257817.29883.48
• 46 Turc G, Sallem A, Moulin S, Tisserand M, Machet A, Edjlali M et al. Microbleed Status and 3-Month Outcome After Intravenous Thrombolysis in 717 Patients With Acute Ischemic Stroke. Stroke. 2015;46(9):2458-63. http://doi.org/10.1161/STROKEAHA.115.009290
• 47 Teter B, Ashford JW. Neuroplasticity in Alzheimer’s disease. J Neurosci Res. 2002;70(3):402-37. http://doi.org/10.1002/jnr.10441
• 48 Alshekhlee A, Li CC, Chuang SY, Vora N, Edgell RC, Kitchener JM et al. Does dementia increase risk of thrombolysis? A case-control study. Neurology. 2011;76(18):1575-80. http://doi.org/10.1212/WNL.0b013e3182190d37
• 49 Busl KM, Nogueira RG, Yoo AJ, Hirsch JA, Schwamm LH, Rost NS. Prestroke dementia is associated with poor outcomes after reperfusion therapy among elderly stroke patients. J Stroke Cerebrovasc Dis. 2013;22(6):718-24. http://doi.org/10.1016/j.jstrokecerebrovasdis.2011.11.005
• 50 Saposnik G, Kapral MK, Cote R, Rochon PA, Wang J, Raptis S, et al. Is pre-existing dementia an independent predictor of outcome after stroke? A propensity score-matched analysis. J Neurol. 2012;259(11):2366-75. http://doi.org/10.1007/s00415-012-6508-4
• 51 Arima H, Chalmers J, Woodward M, Anderson C, Rodgers A, Davis S et al. Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial. J Hypertens. 2006;24(6):1201-8. http://doi.org/10.1097/01.hjh.0000226212.34055.86
• 52 McKinney JS, Kostis WJ. Statin therapy and the risk of intracerebral hemorrhage: a meta-analysis of 31 randomized controlled trials. Stroke. 2012;43(8):2149-56. http://doi.org/10.1161/STROKEAHA.112.655894
• 53 Gallagher AM, Rietbrock S, Plumb J, Staa TP. Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis? J Thromb Haemost. 2008;6(9):1500-6. http://doi.org/10.1111/j.1538-7836.2008.03059.x
• 54 Flaker GC, Pogue J, Yusuf S, Pfeffer MA, Goldhaber SZ, Granger CB et al. Cognitive function and anticoagulation control in patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes. 2010;3(3):277-83. http://doi.org/10.1161/CIRCOUTCOMES.109.884171